Product Reports Resources Pricing Login Book a demo

Rainbow Hospitals

Biotech & Life Sciences · Hyderabad, India · Founded 1999

Childrens Hospital in Hyderabad |Best New Born ICU|Secunderabad | Pediatric, Maternity Hospitals MoreLess

Rainbow Children's Medicare Limited operates as a prominent pediatric multi-specialty and perinatal care hospital chain in India, analyzed as a significant entity in the specialized healthcare sector. The company was founded in 1999 by Dr. Ramesh Kancharla, who serves as the Chairman and Managing Director, alongside Dr. Dinesh Kumar Chirla, a neonatal surgeon. Dr. Kancharla, a pediatric gastroenterologist, gained extensive experience in the UK at institutions like Great Ormond Street Children's Hospital before returning to India. This experience was foundational to establishing Rainbow, with the goal of bringing a multi-disciplinary, consultant-led institutional model, similar to the UK's NHS, to India.

The journey began with a single 50-bed pediatric hospital in Banjara Hills, Hyderabad, on November 14, 1999. This first facility quickly established a reputation for its 24-hour consultant-led intensive care and its ability to manage very sick children, including providing a transport facility to bring in patients from surrounding districts. A significant milestone was the expansion into perinatal services in 2007 with the launch of "BirthRight by Rainbow Hospitals," a brand focused on obstetrics, gynecology, and fetal medicine, providing comprehensive care for mothers and newborns, especially in high-risk pregnancies. This integration created synergies, as the benefits of birthing within a children's hospital became evident. The company went public with an Initial Public Offering (IPO) in April 2022, listing on the BSE and NSE stock exchanges on May 10, 2022.

Rainbow's business model is centered on a hub-and-spoke network, where large, comprehensive 'hub' hospitals with tertiary and quaternary care capabilities support smaller 'spoke' facilities that provide secondary care and outpatient services. This asset-light model is designed for operational efficiency and faster expansion. Revenue is primarily generated from patient care services, including hospital services (inpatient and outpatient care), diagnostics, and consultations. In fiscal year 2022, hospital services accounted for approximately 74% of total revenue, with diagnostics contributing around 15% and outpatient services about 11%. The company operates a network of 19 hospitals and multiple clinics across cities like Hyderabad, Bangalore, Delhi, Chennai, Vijayawada, and Visakhapatnam.

The hospital chain offers a wide array of specialized services. For children, this includes neonatal and pediatric intensive care, pediatric multi-specialty services, and quaternary care like multi-organ transplants. Key pediatric departments cover neurology, gastroenterology, oncology, orthopedics, and cardiology, including the dedicated Rainbow Children's Heart Institute established in 2018. The women's care services under the 'BirthRight' brand encompass everything from fertility treatments and normal or complex obstetric care to perinatal genetics and multi-disciplinary fetal medicine. A key operational distinction is its doctor engagement model, which relies on full-time doctors who do not practice elsewhere, ensuring consistent, round-the-clock care.

Keywords: pediatric healthcare, perinatal care, maternity services, hospital chain India, multi-specialty pediatrics, neonatal intensive care (NICU), obstetrics and gynecology, Dr. Ramesh Kancharla, BirthRight by Rainbow, hospital hub-and-spoke model, pediatric surgery, fetal medicine, women and child care, Hyderabad healthcare, Rainbow Children's Heart Institute, pediatric quaternary care, pediatric organ transplants, high-risk pregnancy care, fertility services, Indian healthcare market, publicly listed hospital

Company overview

Rainbow Hospitals company information

The essential company record, classifications and operating signals in one place.

Status
Operational
Founded
1999
Headquarters
Hyderabad, India
Employees
2,881
Open positions
11
Dealroom signal
89.3
Investment activity
2 companies · latest Aug 2025
Capital deployed
Preferred round
ACQUISITION
client focusb2csub industryBioTechnologysub industryHealth PlatformindustryHealthsectorBiotechnologysectorChildrensectorPatient CaresectorHospitalsectorArts & CulturesectorBiotech and PharmasectorHard TechsectorDT and LSsectorscience-based

Valuation & funding

Rainbow Hospitals funding history

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
IPOOther financing Apr 2022 $0 Undisclosed
LATE VCOther financing Apr 2022 $61M $245M HSBC · Reliance Nippon Life Asset Management · UTI Mutual Fund · IIFL
DEBTDebt Aug 2016 $15M British International Investment
LATE VCOther financing Aug 2013 $20M $78M CDC Group
Showing 4 recorded eventsUnlock the complete deal history →

Financials

Revenue and workforce over time

Available revenue and workforce history. Fields without reported data are omitted.

YearRevenueGrowthEmployees
2026 $231M +12.4% 2,881
2025 $206M +16.6% 2,576
2024 $177M +10.8% 2,178
2023 $159M +20.5% 1,737
2022 $132M +66.7% 1,233
2021 $79M -18.8% 892
2020 $98M 682
Company filings, research estimates and Dealroom dataOpen the full financial model →

Growth signals

Rainbow Hospitals website traffic

Latest recorded traffic for Rainbow Hospitals is 300K monthly website visits, up 66.7% over the last three months. Rainbow Hospitals's team grew 11.8% over the past year.

Latest monthly visits300K 3-month web change+66.7% 1-year team growth+11.8%
Monthly website visits124 observations · Apr 2016–Jul 2026
Hover or focus a point to see its exact monthly valueCompare with peers →

Comparisons

Rainbow Hospitals compared with similar companies

Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.

CompanyHeadquartersStatusEmployeesTotal fundingValuation
IceCure MedicalDevelops and markets minimally invasive cryoablation therapies for the treatment of breast cancer Caesarea, Israel Operational 78 $14M $45M
P-CureP-Cure is a biotech company has developed a patient centric proton therapy solution with clinical benefits and financial advantages Shilat, Israel Operational
The Dermatology GroupA dermatology-focused physician practice management company with 16 company affiliated locations throughout Northern and Central New Jersey United States Operational
Galil MedicalGalil Medical develops cryotherapy solutions that address patient conditions across multiple physician specialties Saint Paul, United States Acquired
OncoStatsSoftware that was developed to solve specific problems regarding clinical data records in Oncology Braga, Portugal Operational
HeymedicaA platform that unites all providers of medical services, hospitals, clinics, analysis laboratories, pharmacies, dentists, specialists and family doctors and connects them with all patients Alba Iulia, Romania Operational
OptimedisBuilding an integrated healthcare structure in which doctors, therapists, hospitals, pharmacies and others work in association and overcome past constraints Hamburg, Germany Operational
Pendulum TherapeuticsMicrobiome company focused on enabling better patient care through targeted equilibration of human microbiomes San Francisco, United States Operational
Showing 8 of the closest matchesCompare every metric →

Talent graph

Rainbow Hospitals's talent

Book a demo to see the people
Team profiled 10 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 4 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

20 investors on Rainbow Hospitals's cap table

Sourced from Dealroom's funding and investor records. Investor profile links are shown where available.

Series B+ 19 investors entered at this stage
CDC Group
British International Investment
HSBC
Reliance Nippon Life Asset Management
UTI Mutual Fund
IIFL
Monetary Authority Of Singapore
Ashoka India Opportunities Fund
Baroda BNP Paribas Mutual Fund
Neuberger Berman
Goldman Sachs Asset Management
Max Life insurance
HDFC Life
Government of Singapore
Axis Mutual Fund
Matthews Asia
Amansa Holdings
DSP Mutual Fund
Motilal Oswal Mutual Fund
Other known 1 additional known investor
Abraaj Group

Global footprint

Where Rainbow Hospitals has talent and traffic

Workforce by country
13 countries with
team presence
🇮🇳 India97.2%
🇦🇪 United Arab Emirates0.8%
🇺🇸 United States0.5%
🇬🇧 United Kingdom0.4%
🇦🇺 Australia0.2%
Top 5 of 13 shown

In the news

Latest news about Rainbow Hospitals

Recent press, funding announcements, and product moves mentioning Rainbow Hospitals — open to read from the original sources.

See all news

Market sentiment

What the market is saying about Rainbow Hospitals

An AI-synthesized read of the highest-engagement posts about Rainbow Hospitals on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Rainbow Hospitals’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.